AIM: To probe into the clinical value of danshen injection iontophoresis in treatment of vitreous hemorrhage.

METHODS: Eighty-eight vitreous hemorrhage patients(88 eyes)were selected from June 2012 to June 2013 in our hospital. The patients were divided into observation group and control group randomly, with 44 cases(44 eyes)in each group. The patients in control group were treated with xueshuantong clinical drug treatment. The patients in observation group were treated with danshen injection iontophoresis clinical drug treatment. The clinical treatment and visual recovery situations of the patients in two groups were compared and analyzed.

RESULTS: The cure rate and total effective rate of observation group were 75% and 95%. The cure rate and total effective rate of control group were 59% and 77%. There were statistically significant differences(P<0.05). Compared with control group, the rate of patients in observation group with visual acuity between 0.6 to 0.9 was improved significantly, rate of visual acuity less 0.2 was reduced significantly, and the whole blood viscosity, plasma viscosity, hematocrit and fibrinogen were improved significantly, there were statistical significance(P<0.05).

CONCLUSION: Danshen injection iontophoresis therapy has positive role in improving clinical outcomes and promoting visual function for patients with vitreous hemorrhage.